| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.9 |